[Cerebral infarct: new pathogenetic and therapeutic concepts in the light of 419 cases].
D000925:Anticoagulants / Q000628:therapy*; D002543:Cerebral Hemorrhage; D002544:Cerebral Infarction; D006801:Humans; D020766:Intracranial Embolism; D002542:Intracranial Embolism and Thrombosis; D009525:Niacin / Q000628:therapy*; D010208:Papaverine / Q000628:therapy*; D013927:Thrombosis; D014665:Vasodilator Agents / Q000628:therapy*
D000925:Anticoagulants; D014665:Vasodilator Agents; D009525:Niacin; D010208:Papaverine
ANTICOAGULANTS/therapy; CEREBRAL EMBOLISM AND THROMBOSIS; CEREBRAL HEMORRHAGE; NICOTINIC ACID/therapy; PAPAVERINE/therapy; VASODILATOR AGENTS/therapy